Advances in Hematological Malignancies
Recent decades have witnessed remarkable strides in the domain of hematological malignancies. Novel approaches such as targeted drugs, immunotherapies, and gene editing are altering the prognosis for patients with blood cancers. Ongoing investigations continue to explore these innovative techniques, offering potential for more effective treatment o